Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
CC BY
Lưu vào:
| Tác giả chính: | , , |
|---|---|
| Định dạng: | Sách |
| Ngôn ngữ: | English |
| Nhà xuất bản: |
Springer
2023
|
| Chủ đề: | |
| Truy cập trực tuyến: | https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 |
| Từ khóa: |
Thêm từ khóa
Không có từ khóa, Hãy là người đầu tiên đánh dấu biểu ghi này!
|
| id |
oai:localhost:PNK-7068 |
|---|---|
| record_format |
dspace |
| spelling |
oai:localhost:PNK-70682023-03-22T09:08:46Z Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia CC BY The pivotal ASPECT-NP trial showed ceftolozane/tazobactam was non-inferior to meropenem for the treatment of ventilated hospital-acquired/ventilator-associated bacterial pneumonia (vHABP/VABP). Here, we evaluated treatment outcomes by degree of respiratory or cardiovascular dysfunction. 2023-03-22T09:08:46Z 2023-03-22T09:08:46Z 2023 Book https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 en application/pdf Springer |
| institution |
Digital Phenikaa |
| collection |
Digital Phenikaa |
| language |
English |
| topic |
pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia |
| spellingShingle |
pivotal ASPECT-NP tria ventilator-associated bacterial pneumonia Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| description |
CC BY |
| format |
Book |
| author |
Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink |
| author_facet |
Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink |
| author_sort |
Ignacio, Martin-Loeches |
| title |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| title_short |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| title_full |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| title_fullStr |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| title_full_unstemmed |
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| title_sort |
outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled aspect-np trial |
| publisher |
Springer |
| publishDate |
2023 |
| url |
https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 |
| _version_ |
1761097142432169984 |
| score |
8.893527 |